The DAWBA anxiety band scores (GAD, Sep AD, and Social AD) at baseline (n = 19) did not significantly predict the SCARED-CP difference score (Table 2), which captures the change in anxiety symptom severity across treatment (Fig. 3). This evidence concerns the gene GAD1 and Alzheimer disease.